Chris Shibutani's Stock Ratings

Goldman Sachs Analyst

Chris Shibutani is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

0.85%

Smart Score

54.3%

Overall Average Return Percentile

40th

Number of Ratings

114
Buy NowGet Alert
03/14/2025MCRBBuy Now
Seres Therapeutics
$0.77-2.6%
Chris Shibutani54%
$1 → $0.75MaintainsSellGet Alert
02/14/2025ALKSBuy Now
Alkermes
$33.03-3.12%
Chris Shibutani54%
$30 → $32MaintainsBuyGet Alert
12/20/2024PCVXBuy Now
Vaxcyte
$76.1477.3%
Chris Shibutani54%
→ $135Initiates → BuyGet Alert
11/08/2024BNTXBuy Now
BioNTech
$99.0138.37%
Chris Shibutani54%
$90 → $137UpgradeNeutral → BuyGet Alert
11/07/2024SNDXBuy Now
Syndax Pharmaceuticals
$13.14151.14%
Chris Shibutani54%
$30 → $33MaintainsBuyGet Alert
11/01/2024UTHRBuy Now
United Therapeutics
$318.86-5.29%
Chris Shibutani54%
$243 → $302MaintainsNeutralGet Alert
10/25/2024ALKSBuy Now
Alkermes
$33.03-9.17%
Chris Shibutani54%
$32 → $30MaintainsBuyGet Alert
10/25/2024ERASBuy Now
Erasca
$1.49134.9%
Chris Shibutani54%
$3 → $3.5MaintainsBuyGet Alert
08/14/2024ERASBuy Now
Erasca
$1.49101.34%
Chris Shibutani54%
$4 → $3MaintainsBuyGet Alert
08/14/2024RPRXBuy Now
Royalty Pharma
$33.5452.06%
Chris Shibutani54%
$50 → $51MaintainsBuyGet Alert
07/19/2024JNJBuy Now
Johnson & Johnson
$163.00-4.91%
Chris Shibutani54%
$160 → $155MaintainsNeutralGet Alert
07/12/2024AMLXBuy Now
Amylyx Pharma
$3.659.59%
Chris Shibutani54%
$3 → $4MaintainsNeutralGet Alert
05/28/2024ERASBuy Now
Erasca
$1.49168.46%
Chris Shibutani54%
$7 → $4MaintainsBuyGet Alert
05/13/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$9 → $8MaintainsNeutralGet Alert
05/06/2024OGNBuy Now
Organon
$15.8726.02%
Chris Shibutani54%
$18 → $20MaintainsNeutralGet Alert
05/03/2024UTHRBuy Now
United Therapeutics
$318.86-24.73%
Chris Shibutani54%
$218 → $240MaintainsNeutralGet Alert
05/03/2024OGNBuy Now
Organon
$15.8726.02%
Chris Shibutani54%
$18 → $20MaintainsNeutralGet Alert
04/11/2024LLYBuy Now
Eli Lilly and Co
$839.90-13.92%
Chris Shibutani54%
$650 → $723MaintainsNeutralGet Alert
04/02/2024ERASBuy Now
Erasca
$1.49369.8%
Chris Shibutani54%
$6 → $7MaintainsBuyGet Alert
03/11/2024AMLXBuy Now
Amylyx Pharma
$3.659.59%
Chris Shibutani54%
$40 → $4DowngradeBuy → NeutralGet Alert
03/01/2024SDGRBuy Now
Schrodinger
$22.5115.5%
Chris Shibutani54%
$29 → $26MaintainsNeutralGet Alert
03/01/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$8 → $9MaintainsNeutralGet Alert
02/28/2024BNTXBuy Now
BioNTech
$99.011%
Chris Shibutani54%
$113 → $100MaintainsNeutralGet Alert
02/20/2024RPRXBuy Now
Royalty Pharma
$33.5449.08%
Chris Shibutani54%
$56 → $50MaintainsBuyGet Alert
02/20/2024OGNBuy Now
Organon
$15.8713.42%
Chris Shibutani54%
$16 → $18MaintainsNeutralGet Alert
02/12/2024UTHRBuy Now
United Therapeutics
$318.86-32.57%
Chris Shibutani54%
$213 → $215UpgradeSell → NeutralGet Alert
01/25/2024NBIXBuy Now
Neurocrine Biosciences
$109.7139.46%
Chris Shibutani54%
$134 → $153MaintainsBuyGet Alert
01/09/2024RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$30 → $8DowngradeBuy → NeutralGet Alert
12/11/2023ABBVBuy Now
AbbVie
$212.25-18.49%
Chris Shibutani54%
→ $173UpgradeNeutral → BuyGet Alert
11/10/2023AMLXBuy Now
Amylyx Pharma
$3.65995.89%
Chris Shibutani54%
$46 → $40MaintainsBuyGet Alert
11/09/2023NKTRBuy Now
Nektar Therapeutics
$0.88
Chris Shibutani54%
UpgradeMarket Perform → OutperformGet Alert
11/03/2023MCRBBuy Now
Seres Therapeutics
$0.7762.34%
Chris Shibutani54%
$4 → $1.25MaintainsSellGet Alert
11/03/2023OGNBuy Now
Organon
$15.870.82%
Chris Shibutani54%
$33 → $16DowngradeBuy → NeutralGet Alert
10/30/2023BMYBuy Now
Bristol-Myers Squibb
$60.0015%
Chris Shibutani54%
$81 → $69MaintainsBuyGet Alert
10/11/2023SNDXBuy Now
Syndax Pharmaceuticals
$13.14128.31%
Chris Shibutani54%
→ $30Initiates → BuyGet Alert
09/21/2023RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
$38 → $33MaintainsBuyGet Alert
08/10/2023LLYBuy Now
Eli Lilly
$839.90-44.04%
Chris Shibutani54%
$385 → $470MaintainsNeutralGet Alert
08/09/2023LLYBuy Now
Eli Lilly
$839.90-44.04%
Chris Shibutani54%
$385 → $470MaintainsNeutralGet Alert
07/24/2023AMLXBuy Now
Amylyx Pharma
$3.651242.47%
Chris Shibutani54%
$45 → $49UpgradeNeutral → BuyGet Alert
05/16/2023ERASBuy Now
Erasca
$1.49504.03%
Chris Shibutani54%
$10 → $9MaintainsBuyGet Alert
05/10/2023EQRXBuy Now
EQRx
Chris Shibutani54%
$5 → $3MaintainsNeutralGet Alert
03/28/2023BNTXBuy Now
BioNTech
$99.0141.4%
Chris Shibutani54%
$156 → $140MaintainsNeutralGet Alert
03/14/2023AMLXBuy Now
Amylyx Pharma
$3.651187.67%
Chris Shibutani54%
$41 → $47MaintainsNeutralGet Alert
03/03/2023INVABuy Now
Innoviva
$17.15-24.2%
Chris Shibutani54%
$15 → $13MaintainsNeutralGet Alert
03/01/2023RVMDBuy Now
Revolution Medicines
$38.75-40.65%
Chris Shibutani54%
$20 → $23MaintainsNeutralGet Alert
02/27/2023NKTRBuy Now
Nektar Therapeutics
$0.88127.25%
Chris Shibutani54%
$3 → $2MaintainsSellGet Alert
02/24/2023ERASBuy Now
Erasca
$1.49571.14%
Chris Shibutani54%
→ $10Initiates → BuyGet Alert
01/31/2023RXDXBuy Now
Prometheus Biosciences
Chris Shibutani54%
$117 → $144MaintainsBuyGet Alert
01/31/2023BNTXBuy Now
BioNTech
$99.0157.56%
Chris Shibutani54%
$177 → $156MaintainsNeutralGet Alert
12/19/2022VTYXBuy Now
Ventyx Biosciences
$1.363576.74%
Chris Shibutani54%
→ $50Initiates → BuyGet Alert
12/16/2022KYMRBuy Now
Kymera Therapeutics
$33.8753.53%
Chris Shibutani54%
$40 → $52MaintainsBuyGet Alert
12/13/2022PFEBuy Now
Pfizer
$26.22128.83%
Chris Shibutani54%
$47 → $60UpgradeNeutral → BuyGet Alert
12/05/2022UTHRBuy Now
United Therapeutics
$318.86-27.87%
Chris Shibutani54%
→ $230Initiates → SellGet Alert
11/11/2022EQRXBuy Now
EQRx
Chris Shibutani54%
$8 → $5DowngradeBuy → NeutralGet Alert
11/08/2022TRDABuy Now
Entrada Therapeutics
$10.7567.44%
Chris Shibutani54%
$13 → $18MaintainsNeutralGet Alert
11/08/2022LLYBuy Now
Eli Lilly
$839.90-62.73%
Chris Shibutani54%
$281 → $313MaintainsNeutralGet Alert
11/08/2022BNTXBuy Now
BioNTech
$99.0178.77%
Chris Shibutani54%
$200 → $177MaintainsNeutralGet Alert
09/22/2022RVNCBuy Now
Revance Therapeutics
Chris Shibutani54%
→ $33Initiates → BuyGet Alert
09/09/2022AMLXBuy Now
Amylyx Pharma
$3.65995.89%
Chris Shibutani54%
$22 → $40MaintainsNeutralGet Alert
08/16/2022TRDABuy Now
Entrada Therapeutics
$10.7520.93%
Chris Shibutani54%
$10 → $13MaintainsNeutralGet Alert
08/03/2022KYMRBuy Now
Kymera Therapeutics
$33.8718.1%
Chris Shibutani54%
→ $40Initiates → BuyGet Alert
07/20/2022INVABuy Now
Innoviva
$17.15-6.71%
Chris Shibutani54%
→ $16Initiates → NeutralGet Alert
07/20/2022RXDXBuy Now
Prometheus Biosciences
Chris Shibutani54%
→ $51Initiates → BuyGet Alert
06/13/2022EQRXBuy Now
EQRx
Chris Shibutani54%
→ $8Initiates → BuyGet Alert
05/24/2022EXAIBuy Now
Exscientia
Chris Shibutani54%
$23 → $20MaintainsBuyGet Alert
05/24/2022TRDABuy Now
Entrada Therapeutics
$10.75-6.98%
Chris Shibutani54%
$22 → $10MaintainsNeutralGet Alert
05/24/2022BNTXBuy Now
BioNTech
$99.01108.06%
Chris Shibutani54%
$255 → $206MaintainsNeutralGet Alert
04/27/2022OGNBuy Now
Organon
$15.87152.05%
Chris Shibutani54%
→ $40Initiates → BuyGet Alert
04/27/2022RPRXBuy Now
Royalty Pharma
$33.5466.96%
Chris Shibutani54%
→ $56Initiates → BuyGet Alert
04/20/2022ALKSBuy Now
Alkermes
$33.035.96%
Chris Shibutani54%
→ $35Initiates → BuyGet Alert
04/18/2022NKTRBuy Now
Nektar Therapeutics
$0.88240.87%
Chris Shibutani54%
→ $3DowngradeNeutral → SellGet Alert
04/12/2022JNJBuy Now
Johnson & Johnson
$163.0011.04%
Chris Shibutani54%
$163 → $181MaintainsNeutralGet Alert
04/12/2022LLYBuy Now
Eli Lilly
$839.90-68.57%
Chris Shibutani54%
$234 → $264MaintainsNeutralGet Alert
04/12/2022ABBVBuy Now
AbbVie
$212.25-34.04%
Chris Shibutani54%
$122 → $140MaintainsNeutralGet Alert
04/01/2022AMLXBuy Now
Amylyx Pharma
$3.65173.97%
Chris Shibutani54%
$36 → $10DowngradeBuy → NeutralGet Alert
02/25/2022NBIXBuy Now
Neurocrine Biosciences
$109.714.82%
Chris Shibutani54%
→ $115UpgradeNeutral → BuyGet Alert
02/03/2022ABBVBuy Now
AbbVie
$212.25-42.52%
Chris Shibutani54%
$117 → $122MaintainsNeutralGet Alert
02/01/2022AMLXBuy Now
Amylyx Pharma
$3.65886.3%
Chris Shibutani54%
→ $36Initiates → BuyGet Alert
12/17/2021ABBVBuy Now
AbbVie
$212.25-46.76%
Chris Shibutani54%
→ $113Initiates → NeutralGet Alert
12/17/2021PFEBuy Now
Pfizer
$26.2294.51%
Chris Shibutani54%
→ $51Initiates → NeutralGet Alert
12/17/2021JNJBuy Now
Johnson & Johnson
$163.00-1.23%
Chris Shibutani54%
→ $161Initiates → NeutralGet Alert
12/17/2021LLYBuy Now
Eli Lilly
$839.90-71.9%
Chris Shibutani54%
→ $236Initiates → NeutralGet Alert
12/17/2021BMYBuy Now
Bristol-Myers Squibb
$60.0020%
Chris Shibutani54%
→ $72Initiates → BuyGet Alert
11/23/2021TRDABuy Now
Entrada Therapeutics
$10.75169.77%
Chris Shibutani54%
→ $29Initiates → NeutralGet Alert
10/26/2021EXAIBuy Now
Exscientia
Chris Shibutani54%
→ $30Initiates → BuyGet Alert
09/07/2021TNGXBuy Now
Tango Therapeutics
$1.68911.9%
Chris Shibutani54%
→ $17Initiates → BuyGet Alert
08/12/2021RVMDBuy Now
Revolution Medicines
$38.75-30.32%
Chris Shibutani54%
$49 → $27DowngradeBuy → NeutralGet Alert
07/23/2021MCRBBuy Now
Seres Therapeutics
$0.77809.09%
Chris Shibutani54%
$24 → $7DowngradeNeutral → SellGet Alert
05/18/2021ARNABuy Now
Arena Pharmaceuticals
Chris Shibutani54%
→ $90Initiates → BuyGet Alert
05/18/2021BNTXBuy Now
BioNTech
$99.0174.73%
Chris Shibutani54%
→ $173Initiates → NeutralGet Alert
05/18/2021RVMDBuy Now
Revolution Medicines
$38.7526.45%
Chris Shibutani54%
→ $49Initiates → BuyGet Alert
07/14/2020RPTXBuy Now
Repare Therapeutics
$1.11
Chris Shibutani54%
Initiates → OutperformGet Alert
02/10/2020ARDXBuy Now
Ardelyx
$5.35
Chris Shibutani54%
Initiates → OutperformGet Alert
01/10/2020ADROBuy Now
Aduro Biotech
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
07/15/2019ALKSBuy Now
Alkermes
$33.03-18.26%
Chris Shibutani54%
→ $27UpgradeSell → NeutralGet Alert
05/28/2019BMYBuy Now
Bristol-Myers Squibb
$60.00-10%
Chris Shibutani54%
→ $54Initiates → BuyGet Alert
12/19/2018ALKSBuy Now
Alkermes
$33.03-21.28%
Chris Shibutani54%
$49 → $26DowngradeNeutral → SellGet Alert
01/24/2018PBYIBuy Now
Puma Biotechnology
$3.45
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
12/21/2017MRTXBuy Now
Mirati Therapeutics
Chris Shibutani54%
Initiates → OutperformGet Alert
11/07/2017NKTRBuy Now
Nektar Therapeutics
$0.88
Chris Shibutani54%
Initiates → OutperformGet Alert
07/18/2017ADROBuy Now
Aduro Biotech
Chris Shibutani54%
Initiates → OutperformGet Alert
05/25/2017PBYIBuy Now
Puma Biotechnology
$3.45
Chris Shibutani54%
UpgradeMarket Perform → OutperformGet Alert
05/02/2017RDUSBuy Now
Radius Health
$29.06
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
03/24/2017FPRXBuy Now
Five Prime Therapeutics
Chris Shibutani54%
Initiates → OutperformGet Alert
03/24/2017SNDXBuy Now
Syndax Pharmaceuticals
$13.14
Chris Shibutani54%
Initiates → OutperformGet Alert
05/06/2016RDUSBuy Now
Radius Health
$29.06
Chris Shibutani54%
Assumes → OutperformGet Alert
07/21/2015MCRBBuy Now
Seres Therapeutics
$0.774575.32%
Chris Shibutani54%
→ $36Initiates → NeutralGet Alert
05/05/2015PBYIBuy Now
Puma Biotechnology
$3.45
Chris Shibutani54%
DowngradeOutperform → Market PerformGet Alert
07/16/2014RDUSBuy Now
Radius Health
$29.06
Chris Shibutani54%
Initiates → OutperformGet Alert
01/05/2014ALKSBuy Now
Alkermes
$33.0312.02%
Chris Shibutani54%
$25 → $37MaintainsNeutralGet Alert
12/19/2012BMYBuy Now
Bristol-Myers Squibb
$60.00-35%
Chris Shibutani54%
$40 → $39MaintainsBuyGet Alert
11/13/2012PBYIBuy Now
Puma Biotech
$3.45
Chris Shibutani54%
Initiates → OutperformGet Alert
09/11/2012BMYBuy Now
Bristol-Myers Squibb
$60.00-33.33%
Chris Shibutani54%
$38 → $40UpgradeBuy → BuyGet Alert
05/18/2012ALKSBuy Now
Alkermes
$33.03-48.53%
Chris Shibutani54%
$18 → $17MaintainsNeutralGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free